Mutual Advisors LLC Has $244,000 Stake in The Clorox Company (NYSE:CLX)
Mutual Advisors LLC Has $244,000 Stake in The Clorox Company (NYSE:CLX)
Mutual Advisors LLC decreased its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 10.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,738 shares of the company's stock after selling 204 shares during the period. Mutual Advisors LLC's holdings in Clorox were worth $244,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. SPC Financial Inc. acquired a new position in shares of Clorox during the 3rd quarter valued at about $200,000. Point72 Hong Kong Ltd bought a new position in Clorox in the 3rd quarter worth approximately $51,000. MML Investors Services LLC increased its position in Clorox by 10.1% in the 3rd quarter. MML Investors Services LLC now owns 24,450 shares of the company's stock worth $3,139,000 after buying an additional 2,234 shares during the period. Exchange Traded Concepts LLC bought a new position in Clorox in the 3rd quarter worth approximately $569,000. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in Clorox by 345.0% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 63,478 shares of the company's stock worth $8,948,000 after buying an additional 49,213 shares during the period. Institutional investors and hedge funds own 79.12% of the company's stock.
Get Clorox alerts:Clorox Price Performance
Shares of CLX stock opened at $157.50 on Monday. The stock's fifty day simple moving average is $150.56 and its 200 day simple moving average is $144.95. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The firm has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a P/E/G ratio of 3.12 and a beta of 0.29. The Clorox Company has a one year low of $120.50 and a one year high of $160.59.
Clorox (NYSE:CLX – Get Rating) last announced its quarterly earnings results on Thursday, February 2nd. The company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.66 by $0.32. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.66 billion. Clorox had a return on equity of 89.97% and a net margin of 6.16%. Clorox's quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 EPS. On average, analysts expect that The Clorox Company will post 4.23 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be paid a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's dividend payout ratio is currently 134.86%.
Analyst Upgrades and Downgrades
Several research analysts have commented on CLX shares. Barclays dropped their price target on Clorox from $110.00 to $108.00 and set an "underweight" rating on the stock in a research report on Monday, February 6th. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. Wells Fargo & Company lifted their price target on Clorox from $125.00 to $135.00 and gave the stock an "underweight" rating in a research report on Tuesday, January 3rd. Raymond James lifted their price target on Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research report on Friday, February 3rd. Finally, Jefferies Financial Group boosted their price objective on Clorox from $140.00 to $145.00 and gave the company a "hold" rating in a research report on Wednesday, February 1st. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $141.00.
Clorox Company Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Further Reading
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
根據互惠顧問公司最近提交給美國證券交易委員會的檔案,該公司在第四季度減持了高樂氏公司的股票10.5%。該基金在此期間出售了204股後,持有1,738股該公司股票。截至最近向美國證券交易委員會提交的檔案,Mutual Advisors LLC持有的高樂氏股份價值24.4萬美元。
其他對沖基金也對他們在該公司的頭寸進行了調整。SPC Financial Inc.在第三季度收購了價值約20萬美元的高樂氏股票。Point72 Hong Kong Ltd在第三季度購買了價值約51,000美元的高樂氏新頭寸。MML Investors Services LLC在第三季度將其在Clorox的頭寸增加了10.1%。MML Investors Services LLC現在擁有24,450股該公司股票,價值3,139,000美元,在此期間又購買了2,234股。交易所交易的概念有限責任公司在第三季度購買了價值約56.9萬美元的高樂氏新頭寸。最後,DZ銀行股份公司德國中央銀行法蘭克福美因河畔法蘭克福銀行在第二季度增持了345.0%的高樂氏股份。德國美因河畔法蘭克福銀行現在持有63,478股公司股票,價值8,948,000美元,在此期間又購買了49,213股。機構投資者和對沖基金持有該公司79.12%的股票。
到達高樂氏警報:高樂氏性價比
CLX股票週一開盤報157.50美元。該股的50日簡單移動均線切入位為150.56美元,200日簡單移動均線切入位為144.95美元。該公司的債務權益比為5.04,流動比率為0.86,速動比率為0.47。該公司市值為194.6億美元,本益比為45.00倍,本益比為3.12倍,貝塔係數為0.29。高樂氏公司的一年低點為120.50美元,一年高位為160.59美元。
高樂氏(紐約證券交易所代碼:CLX-GET評級)上一次公佈季度收益是在2月2日星期四。該公司公佈本季度每股收益為0.98美元,比普遍預期的0.66美元高出0.32美元。該業務本季度營收為17.2億美元,而分析師預期為16.6億美元。高樂氏的股本回報率為89.97%,淨利潤率為6.16%。高樂氏季度營收同比增長1.4%。去年同期,該公司每股收益為0.66美元。分析師平均預計,高樂氏公司本財年的每股收益將為4.23美元。
高樂氏宣佈分紅
該公司最近還披露了季度股息,將於5月12日(星期五)支付。4月26日(星期三)登記在冊的股東將獲得1.18美元的股息。這意味著年化股息為4.72美元,收益率為3.00%。本次股息除息日期為4月25日(星期二)。高樂氏的股息支付率目前為134.86。
分析師升級和下調評級
幾位研究分析師對CLX的股票發表了評論。巴克萊將高樂氏的目標價從110.00美元下調至108.00美元,並在2月6日週一的一份研究報告中將該股的評級定為“減持”。德意志銀行Aktiengesellschaft在3月20日星期一的一份研究報告中將高樂氏的目標價從152.00美元下調至147.00美元。富國銀行將高樂氏的目標價從125.00美元上調至135.00美元,並在1月3日(星期二)的一份研究報告中給予該股“減持”評級。雷蒙德·詹姆斯將高樂氏的目標價從160.00美元上調至165.00美元,並在2月3日星期五的一份研究報告中給出了該股的評級:跑贏大盤。最後,傑富瑞金融集團將高樂氏的目標價從140.00美元上調至145.00美元,並在2月1日星期三的一份研究報告中給出了該公司“持有”的評級。7名股票研究分析師對該股的評級為賣出,6名分析師給予持有評級,1名分析師對該公司股票給予買入評級。根據MarketBeat的數據,該公司的普遍評級為持有,平均目標價為141.00美元。
高樂氏公司簡介
(獲取評級)
高樂氏公司從事消費品和專業產品的製造和營銷。它通過以下業務部門運營:健康和健康、家庭、生活方式和國際。健康和健康部分包括清潔產品、專業產品和維生素、礦物質和補充劑,主要在美國銷售和銷售。
進一步閱讀
- 免費獲取StockNews.com關於高樂氏的研究報告
- 市場回顧周-3/20-3/24
- 紅利王正品配件公司利潤指引升級
- 埃森哲的底部已經到了
- 2023年11只最佳非必需消費品股票
- 5只最佳股利捕捉股
想看看還有哪些對沖基金持有CLX嗎?訪問HoldingsChannel.com,獲取高樂氏公司(紐約證券交易所代碼:CLX-GET評級)的最新13F檔案和內幕交易。
接受《高樂氏日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Clorox和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧